Results 201 to 210 of about 54,603 (242)

Post-Liver Transplant Kidney Dysfunction: Incidence of Acute Kidney Injury and Chronic Kidney Disease and Risk Factors Related to Chronic Kidney Disease Development. [PDF]

Diseases
Moura AF, Moura-Neto JA, Ribeiro BM, Oliveira PR, Freitas AG, Costa AL, Moura-Landim D, Codes L, Bittencourt PL, Cruz CMS.   +9 more
europepmc   +1 more source

Outcomes for patients with alcohol‐related liver disease admitted to Scottish intensive care units 2010–2018

Anaesthesia, EarlyView.
Summary Introduction Alcohol‐related liver disease is recognised as a major cause of liver‐related morbidity and mortality. Our aim was to report the prevalence of, and outcomes from, alcohol‐related liver disease after admission to ICUs in Scotland. Methods We performed a secondary data analysis using linked Scottish national databases of all adult ...
Alaina Shariff, Stella Rhode, Stuart J. Forbes, Nazir Lone, Annemarie Docherty   +4 more
wiley   +1 more source

Management of chronic hepatitis B in Uganda: A five-year experience following the initiation of a national sensitization and care campaign. [PDF]

J Virus Erad
Seremba E, Ssekitoleko R, Ocanit A, Kagimu MM, Waiswa M, Nankya-Mutyoba J, Akweny E, Bakainaga A, Lawrence MR, Kabugo C, Ocama P.   +10 more
europepmc   +1 more source

Clearance of Hepatitis C Viremia During Direct‐Acting Antiviral Therapy Leads to Rapid Changes in Lipid and Lipoprotein Metabolism

Alimentary Pharmacology &Therapeutics, EarlyView.
HCV clearance during direct‐acting antiviral therapy rapidly increases serum lipids and lipoproteins, potentially elevating cardiovascular risk. These metabolic changes, mediated by genes regulating hepatic lipogenesis, suggest that lipid levels should be closely monitored post‐SVR to assess long‐term cardiovascular implications.
Zahra Sarrafan‐Chaharsoughi, Varun Takyar, Sungyoung Auh, Gavin Nee, Ahmad Alawad, Brent S. Abel, Devika Kapuria, Colleen Byrnes, Anna Wolska, David E. Kleiner, Robert Shamburek, Alan T. Remaley, Marc G. Ghany   +12 more
wiley   +1 more source

RASGRF2 as a potential pathogenic gene mediating the progression of alcoholic hepatitis to alcohol-related cirrhosis and hepatocellular carcinoma. [PDF]

Discov Oncol
Chen Z, Fan D, Hang T, Yue X.
europepmc   +1 more source

A Case Report of a Rapid Development of Hepatocellular Carcinoma (HCC) Within Six Months of Hepatitis C Cure in an Individual With Risk Factors. [PDF]

Cureus
Israr MA.
europepmc   +1 more source

Long-Term Effects of Direct-Acting Antivirals on Hepatitis C: Trends in Liver Disease-Related Hospitalisations in Italy. [PDF]

J Viral Hepat
Mennini FS, Sciattella P, Simonelli C, Marcellusi A, Rosato S, Kondili LA.   +5 more
europepmc   +1 more source

Targeted Plasma Bile Acid Metabolomic Analysis in Metabolic Dysfunction-Associated Steatohepatitis and Alcoholic Hepatitis. [PDF]

Biomedicines
Hirata Y, Sakuma Y, Ogiso H, Nagai R, Aizawa K.   +4 more
europepmc   +1 more source

Evaluating the regional and demographic variables in alcoholic liver disease-related mortality trends in the United States from 1999 to 2020: A cross sectional study. [PDF]

Medicine (Baltimore)
Hayat MS, Shoaib MM, Sohail S, Ahmed S, Shahid F, Ahmad H, Naseer MR, Shoaib MM, Ahmed R.   +8 more
europepmc   +1 more source

Liver transplantation for alcohol-associated liver disease: The changing landscape. [PDF]

Hepatol Forum
Yildiz E, Zaffar D, Ozturk NB, Gurakar M, Donmez AE, Toruner MD, Simsek C, Gurakar A.   +7 more
europepmc   +1 more source